OpenAI's exclusive licensing of GPT-3 to Microsoft, and what this means for ML engineering
ReadHear me talk about machine learning, aging, drug discovery, and a bunch of other topics
ReadRevisiting a resurging NeurIPS 2015 paper (and 25 best practices more relevant than that for 2020)
Read